BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le T, Su S, Shahriyari L. Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model. Cells 2021;10:2009. [PMID: 34440778 DOI: 10.3390/cells10082009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nave O, Sigron M. A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies. Results in Applied Mathematics 2022;16:100330. [DOI: 10.1016/j.rinam.2022.100330] [Reference Citation Analysis]
2 Sofia D, Mohammad Mirzaei N, Shahriyari L. Patient-Specific Mathematical Model of the Clear Cell Renal Cell Carcinoma Microenvironment. J Pers Med 2022;12:1681. [PMID: 36294824 DOI: 10.3390/jpm12101681] [Reference Citation Analysis]
3 Mohammad Mirzaei N, Tatarova Z, Hao W, Changizi N, Asadpoure A, Zervantonakis IK, Hu Y, Chang YH, Shahriyari L. A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice. JPM 2022;12:807. [DOI: 10.3390/jpm12050807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lu Y, Zhang J, Chen Y, Kang Y, Liao Z, He Y, Zhang C. Novel Immunotherapies for Osteosarcoma. Front Oncol 2022;12:830546. [DOI: 10.3389/fonc.2022.830546] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Mohammad Mirzaei N, Changizi N, Asadpoure A, Su S, Sofia D, Tatarova Z, Zervantonakis IK, Chang YH, Shahriyari L. Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model. PLoS Comput Biol 2022;18:e1009953. [PMID: 35294447 DOI: 10.1371/journal.pcbi.1009953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]